Viral Kansara

Viral Kansara

Company: Clearside Biomedical

Job title: Vice President, Preclinical Development


Roundtable Discussion: What is the Ideal Combination of Formulation & Device? 11:00 am

Discussing the Desired Characteristics for a Benchmark: • Assessing different formulations being utilized for ophthalmic delivery and understanding their shortfalls • Discussing the triumphs and tribulations of novel ocular delivery devices, from the hot new suprachoroidal delivery mechanism to the classic intravitreal and subretinal injections and the much-desired topical delivery method • Examining patient concerns…Read more

day: Conference Day Two

Exploring the Latest Developments with Suprachoroidal Delivery 1:30 pm

Suprachoroidal delivery is an emerging delivery route that exploits the suprachoroidal space for less invasive administration and increases the durability of various ophthalmic treatment. With the ongoing preclinical and clinical developments surrounding the use of suprachoroidal delivery for a variety of ophthalmic modalities. Join this workshop to hear the latest developments in this exciting area…Read more

day: Pre-Conference Workshop Day - WORKSHOP E

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.